Table 1 Demographic and clinical characteristics of included patients

Sex [Male, (n, (%))]

49 (73.1%)

Smoking [yes, (n, (%))]

Never

42 (62.7%)

Current

15 (22.4%)

Ex-smoker

10 (14.9%)

BMI

Kg/m², Mean (SD)

25.71 (4.10)

18-24.9 (%)

16 (29.6%)

25-29.9 (%)

26 (48.1%)

>=30 (%)

12 (22.2%)

Hospital stay (days, Mean (SD))

19.42 (14.03)

ICU stay

Frequency (%)

32 (47.8%)

Days, Mean (SD)

16.65 (11.47)

Symptoms of pneumothorax

Increased cough severity

36 (53.7%)

Dyspnea

44 (65.7%)

Chest pain

17 (25.4%)

Hemoptysis

11 (16.4%)

Previous pneumothorax (n, (%))

4 (6%)

comorbidities

HTN (n, (%))

19 (28.4%)

DM (n, (%))

10 (14.9%)

HLP (n, (%))

6 (9%)

Hypothyroidism (n, (%))

7 (10.4%)

Respiratory comorbidities

Asthma (n, (%))

3 (4.5%)

COPD (n, (%))

1 (1.5%)

TB (n, (%))

2 (3%)

Severity of COVID-19

Mild (%)

1 (1.5%)

Moderate (%)

17 (25.4%)

Severe (%)

48 (71.6%)

Lung with more COVID-19 severity

Left (%)

25 (37.3%)

Right (%)

39 (58.2%)

Both (%)

3 (4.5%)

COVID-19 treatments

Remdesivir

53 (79.1%)

Corticosteroids

54 (80.6%)

Tocilizumab

31 (46.3%)

Antibiotics (frequency (%))

47 (70.1%)

WBC (Mean (SD)) /ul

15426.86 (18530.72)/ul

Neutrophil (Mean (SD)) %

76.15 (14.38) %

Lymphocytes (Mean (SD)) %

13.63 (8.52) %

Hemoglobin (Mean (SD)) g/dl

12.73 (2.66)g/dl

Platelet (Mean (SD)) /ul

210246.26 (88050.44)/ul

CRP (Mean (SD)) mg/dl

85.16 (48.95) mg/dl